Federal grants to Texas Heart Institute
Texas Heart Institute in Houston, Texas received $12.4 million in federal grants from fiscal 2021 to 2025, across 12 awards. Its largest program was Cardiovascular Diseases Research, with $12.3 million. In fiscal 2025 it was awarded $3.0 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$12.4 million
- Awards12
- Awarded in FY 2025$3.0 million
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $730,218 |
| FY 2022 | 6 | $3.2 million |
| FY 2023 | 6 | $3.7 million |
| FY 2024 | 4 | $1.8 million |
| FY 2025 | 6 | $3.0 million |
Programs that fund Texas Heart Institute
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 11 | $12.3 million |
| Research Infrastructure Programs | 1 | $220,814 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 12 | $12.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Maglev lvad with expandable stented inlet and anti-thrombotic coating to improve hemocompatibility - project summary/abstract nearly 5 million people in the USA suffer from heart failure, with approximately 400,000 heart failure-related deaths occurring yearly. Heart failure causes a significant pub | Cardiovascular Diseases Research | June 29, 2023 | $2.1 million |
| Development of a fully-implantable ventricular assist device for neonates and children with heart failure - with magnetic levitation to improve hemocompatibility | Cardiovascular Diseases Research | May 19, 2021 | $2.1 million |
| Hippo and wnt signaling in cardiac regeneration | Cardiovascular Diseases Research | January 23, 2021 | $1.8 million |
| Coordinated heart stimulation testbed: a platform for contractile ventricle engineering - project summary heart failure, the main clinical and public health problem, accounts for 13% of deaths in the us. Although transplantation is currently the only therapy for end-stage heart failure, the availabi | Cardiovascular Diseases Research | May 24, 2023 | $1.2 million |
| Leadless wirelessly powered pacemaker for multi chamber pacing using miniaturized pacing and sensing node | Cardiovascular Diseases Research | August 9, 2021 | $1.2 million |
| Targeting integrin signaling in atherosclerosis - cardiovascular disease remains the leading cause of death, worldwide. The most common underlying cause of ischemic heart disease and stroke is atherosclerosis. Three seminal studies, the canakinumab anti-inflammatory thrombosis outcomes study (cantos | Cardiovascular Diseases Research | May 25, 2023 | $1.1 million |
| Optimization of small molecule integrin activators to enhance cord blood transplant - project summary this proposal is in response to the funding opportunity announcement RFA-HL-20-027 for the catalyze: product definition for small molecules and biologics - preliminary product/lead series identifica | Cardiovascular Diseases Research | February 15, 2022 | $1.1 million |
| Senescent cell states in single ventricle disease with heart failure - project summary congenital heart disease (CHD) is the most common birth defect and a leading cause of infant fatality in the united states. With improvements in techniques for medical intervention, more and more newborns with chd | Cardiovascular Diseases Research | December 30, 2024 | $655,636 |
| Targeting senescent macrophages to improve heart failure outcomes - project summary/abstract heart failure (HF) remains a leading cause of morbidity and mortality worldwide. Despite the availability of various therapies, preventing the maladaptive changes associated with hf continues to be a challen | Cardiovascular Diseases Research | July 23, 2025 | $651,967 |
| Targeting integrin signaling in atherosclerosis - cardiovascular disease remains the leading cause of death, worldwide. The most common underlying cause of ischemic heart disease and stroke is atherosclerosis. Three seminal studies, the canakinumab anti-inflammatory thrombosis outcomes study (cantos | Cardiovascular Diseases Research | July 2, 2025 | $534,347 |
Questions people ask
How much federal grant money does Texas Heart Institute get?
$12.4 million in 12 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Texas Heart Institute the most?
The Department of Health and Human Services, with $12.5 million in 12 awards.
What is Texas Heart Institute's largest federal grant?
$2.1 million under Cardiovascular Diseases Research, with its first action in the period on June 29, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Texas Heart Institute?
Its largest are Cardiovascular Diseases Research and Research Infrastructure Programs.
Other grant recipients in Houston
- Baylor College of Medicine
- The Univeristy of Texas M.D. Anderson Cancer Center
- Metropolitan Transit Authority of Harris County
- University of Texas Health Science Center at Houston
- Harris County
- University of Houston System
- William Marsh Rice University
- City of Houston
Largest federal grant recipients in Texas · Federal grants in Texas